July 18, 2024 - $Intuitive Surgical (ISRG.US)$ shares rose 6.81% to $444.49 in post-market trading on Thursday. The company announced financial results for the quarter ended June 30, 2024.

Q2 Highlights

• Worldwide da Vinci procedures grew approximately 17% compared with the second quarter of 2023.

• The Company placed 341 da Vinci surgical systems, compared with 331 in the second quarter of 2023. The second quarter 2024 da Vinci surgical system placements included 70 da Vinci 5 systems.

• The Company grew its da Vinci surgical system installed base to 9,203 systems as of June 30, 2024, an increase of 14% compared with 8,042 as of the end of the second quarter of 2023.

• Second quarter 2024 revenue of $2.01 billion increased 14% compared with $1.76 billion in the second quarter of 2023.

• Second quarter 2024 GAAP net income attributable to Intuitive was $527 million, or $1.46 per diluted share, compared with $421 million, or $1.18 per diluted share, in the second quarter of 2023.

• Second quarter 2024 non-GAAP net income attributable to Intuitive was $641 million, or $1.78 per diluted share, compared with $507 million, or $1.42 per diluted share, in the second quarter of 2023.

About Company

$Intuitive Surgical (ISRG.US)$, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery.  Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.